Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

STF-083010 is an inhibitor of the IRE1/XBP1 pathway, blocking IRE1 endonuclease activity without affecting its kinase activity after endoplasmic reticulum (ER) stress both in vitro and in vivo.1 STF-083010 (60 µM) reduces the splicing of XBP1 by IRE1 in the presence of thapsigargin (Item No. 10522), an ER stress inducer.1 This has cytotoxic effects against multiple myeloma cells and drives apoptosis in pancreatic cancer cells.1,2
WARNING This product is not for human or veterinary use.
1. Identification of an Ire1 alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood 117(4), 1311-1314 (2011).
2. Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells. Oncotarget 5(13), 4881-4894 (2014).